OR WAIT 15 SECS
The expansions included enhancing high-speed automatic syringe assembly and labeling, vial labeling and cartoning, and auto-injector assembly.
PCI Pharma Services announced on June 29, 2020 that it has completed the expansion of its Biotech Packaging Center of Excellence in Philadelphia, PA. The company also revealed new investments into its global biotech packaging capabilities at its operations in Ireland.
According to a company press release, the expansions included enhancing high-speed automatic syringe assembly and labeling, vial labeling and cartoning, and auto-injector assembly. PCI will also build out its cold storage capabilities and manufacturing suites and will continue to provide design teams to address packaging challenges.
“We have already secured projects from numerous global biopharmaceutical customers that will benefit from the new expansion, which is a reflection of the market demand,” said Salim Haffar, CEO, PCI Pharma Services. “We are looking forward to leveraging our breadth of experience with the latest technology to help our customers bring life-changing therapies to patients.”
“With these expansions, our Biotech Centers of Excellence are prepared to support the scale required to meet customers’ needs all over the world,” said Brad Payne, chief operating officer, PCI Pharma Services. “PCI has the flexibility to handle the dynamic volumes of biopharmaceutical therapies, whether large or small, catering to the needs of our global customer base. This flexibility extends to the varied capacities needed for launches, global ramp-up, and ongoing supply. With these investments in high-speed automation, PCI will dramatically improve productivity as well as supply continuity and quality.”